Andropogon virginicus
(A) Bud stage; (B) Flowering stage; (C) Spikelets
Native to the southeastern United States, a weedy grass has spread northward to Canada and also made its way to Australia and Japan. Andropogon virginicus grows densely packed and up to seven feet tall, disrupting growth patterns of other plants and competing for resources. When burned, it grows back stronger. There is no way to effectively remove the weed once it has invaded. But there might be a way to use it to human advantage.
An international team of researchers has found that A. virginicus extracts appear to be effective against several human diseases, including diabetes and cancer. The results were published on Dec. 31, 2020, in a special issue of Plants, titled “Biological Activities of Plant Extracts.”
“A. virginicus is an invasive weed that seriously threatens agricultural production and economics worldwide,” said paper author Tran Dang Xuan, associate professor in the Transdisciplinary Science and Engineering Program in the Graduate School of Advanced Science and Engineering at Hiroshima University. “However, no solution efficiently utilizing and tackling this plant has been found yet. In this paper, we highlight the potential application of A. virginicus extracts in future medicinal production and therapeutics of chronic diseases such as type 2 diabetes and blood cancer, which can deal with both crop protection and human health concerns.”
Researchers found high levels of flavonoids in the samples they extracted from the weed. These plant chemicals have significant antioxidant and anti-inflammatory properties, according to Xuan. When tested against a variety of cell lines, the extracted plant chemicals bonded to free radicals, preventing damage to the cells. At skin level, this helps prevent age spots by inhibiting a protein called tyrosinase. Among other, deeper healthful actions, this bonding also helps prevent knock-on cellular actions that can lead to type 2 diabetes.
The team also specifically applied the extracted chemicals to a line of chronic myelogenous leukemia, a rare blood cancer. The extract appeared to kill off the cancer cells.
Xuan said the researchers plan to establish a comprehensive process to isolate and purify the compounds responsible for known biological properties, as well as work to identify new uses. They will further test the therapeutical effects of the compounds, with the eventual goal of preparing functional pharmaceuticals for human use.
“Although A. virginicus has been considered a harmful invasive species without economic value, its extracts are promising sources of antioxidant, anti-diabetic, anti-tyrosinase, and antitumor agents,” Xuan said.
Original Article: Invasive weed may help treat some human diseases, researchers find
More from: Hiroshima University | Goethe University Frankfurt
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
invasive plant therapeutics
- Differentiated Therapeutics Raises $5 Million Seed Round
Differentiated Therapeutics (dx/tx), a biotech company focused on computationally predicting and optimizing targeted protein degraders (TPDs), today announced the completion of a $5 million Seed ...
- Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S.
and has been granted Orphan Drug Designation for its use in the treatment of invasive candidiasis in both the U.S. and EU. About Cidara Therapeutics This release contains "forward-looking ...
- Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S.
and has been granted Orphan Drug Designation for its use in the treatment of invasive candidiasis in both the U.S. and EU. About Cidara Therapeutics This release contains "forward-looking statements" ...
- Melinta Therapeutics and Cidara Therapeutics Announce Licensing Agreement to Commercialize Rezafungin in the U.S.
and has been granted Orphan Drug Designation for its use in the treatment of invasive candidiasis in both the U.S. and EU. About Cidara Therapeutics ...
- With FDA Submission, Cidara Therapeutics Inks US Pact For Bloodstream Infection Candidate
Cidara Therapeutics Inc (NASDAQ: CDTX) has submitted a marketing application to the FDA seeking approval for rezafungin for candidemia and invasive candidiasis. The company has also entered into a ...
Go deeper with Google Headlines on:
invasive plant therapeutics
Go deeper with Bing News on:
A. virginicus
- Sally Scalera: These flowering trees can provide shade and color to your Brevard landscape
These trees are native to Florida. Fringetree (Chionanthus virginicus) is deciduous, 12 to 20 feet tall and 10 to 15 feet wide. White flowers are produced in the spring and are followed by berries ...
Go deeper with Google Headlines on:
A. virginicus








